DnB Asset Management
MBOT icon

DnB Asset Management’s Microbot Medical MBOT Stock Holding History

DnB Asset Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Hold
677,498
– – ﹤0.01% 626
2026
Q1 		$1.63M Hold
677,498
– – 0.01% 604
2025
Q4 		$1.35M Buy
677,498
+433,869
+178% +$1.03M ﹤0.01% 622
2025
Q3 		$743K Buy
243,629
+50,843
+26% +$159K ﹤0.01% 649
2025
Q2 		$486K Buy
192,786
+77,965
+68% +$187K ﹤0.01% 651
2025
Q1 		$173K Buy
+114,821
New +$203K ﹤0.01% 707

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DnB Asset Management's MBOT Position: Q2 2026 in Review

DnB Asset Management held its Microbot Medical (MBOT) position steady in Q2 2026 at 677,498 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #626.

DnB Asset Management first reported a position in MBOT in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.63M in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • DnB Asset Management held 677,498 shares of Microbot Medical worth $1.32M as of Q2 2026.
  • DnB Asset Management left its Microbot Medical share count unchanged in Q2 2026.
  • Microbot Medical made up ﹤0.01% of DnB Asset Management's portfolio in Q2 2026, its #626 holding.
  • DnB Asset Management first reported a position in Microbot Medical in Q1 2025 and has held it in 6 quarters since.
  • DnB Asset Management's Microbot Medical position peaked at $1.63M in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.